Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.
While our treatments for multiple myeloma (MM) are improving all the time, the best time to eradicate disease is early on. Here, Jesús San Miguel, MD, PhD, of the University of Navarra, Pamplona, Spain, discusses the importance of early intervention from the European School of Haematology (ESH) International Conference on MM 2018, held in Mandelieu, France.
We use cookies to provide the best experience on our website. We also use third party cookies to collect analytical data and better improve our marketing strategies. If you continue to use this site you are consenting to the use of these cookies. For more information view our Cookie Policy.